US Stock MarketDetailed Quotes

JSPR Jasper Therapeutics

Watchlist
  • 21.160
  • +0.920+4.55%
Close Jul 22 16:00 ET
  • 21.250
  • +0.090+0.43%
Post 17:52 ET
319.21MMarket Cap-3785P/E (TTM)

Jasper Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
8.07%15.07M
34.50%68.86M
28.94%17.73M
52.36%19.36M
49.02%17.83M
9.15%13.95M
38.99%51.2M
13.78%13.75M
26.08%12.71M
42.11%11.96M
Selling and administrative expenses
15.26%4.77M
3.06%17.08M
-12.88%3.89M
22.46%4.51M
18.34%4.53M
-9.76%4.14M
45.19%16.57M
30.36%4.47M
27.50%3.69M
17.35%3.83M
-General and administrative expense
15.26%4.77M
3.06%17.08M
-12.88%3.89M
22.46%4.51M
18.34%4.53M
-9.76%4.14M
45.19%16.57M
30.36%4.47M
27.50%3.69M
17.35%3.83M
Research and development costs
5.03%10.3M
49.55%51.79M
49.05%13.84M
64.58%14.85M
63.45%13.3M
19.75%9.81M
36.21%34.63M
7.22%9.28M
25.51%9.02M
57.78%8.14M
Operating profit
-8.07%-15.07M
-34.50%-68.86M
-28.94%-17.73M
-52.36%-19.36M
-49.02%-17.83M
-9.15%-13.95M
-38.99%-51.2M
-13.78%-13.75M
-26.08%-12.71M
-42.11%-11.96M
Net non-operating interest income expense
26.46%1.39M
641.65%5.2M
254.60%1.23M
453.28%1.43M
1,460.87%1.44M
54,700.00%1.1M
701K
348K
2,977.78%259K
92K
Non-operating interest income
26.46%1.39M
641.65%5.2M
254.60%1.23M
453.28%1.43M
1,460.87%1.44M
54,700.00%1.1M
--701K
--348K
--259K
--92K
Other net income (expense)
97.02%-42K
-106.27%-803K
-147.87%-90K
-34.30%385K
-78.80%311K
-113.33%-1.41M
106.75%12.81M
-93.78%188K
-91.22%586K
36,575.00%1.47M
Gain on sale of security
----
-107.99%-575K
--0
----
----
-109.50%-575K
339.92%7.2M
200.00%150K
-65.56%155K
--845K
Special income (charges)
97.38%-20K
-99.69%18K
-67.06%28K
-20.85%334K
-32.80%420K
-116.63%-764K
-38.29%5.73M
-97.21%85K
-93.22%422K
--625K
-Less:Restructuring and merger&acquisition
-97.38%20K
99.69%-18K
67.06%-28K
20.85%-334K
32.80%-420K
116.63%764K
38.29%-5.73M
97.21%-85K
93.22%-422K
---625K
Other non- operating income (expenses)
68.57%-22K
-113.91%-246K
-151.06%-118K
466.67%51K
-3,533.33%-109K
5.41%-70K
-43.75%-115K
---47K
--9K
-175.00%-3K
Income before tax
3.73%-13.73M
-71.06%-64.47M
-25.51%-16.58M
-47.89%-17.54M
-54.56%-16.08M
-546.13%-14.26M
-23.00%-37.69M
-45.87%-13.21M
-247.68%-11.86M
-23.65%-10.4M
Income tax
Net income
3.73%-13.73M
-71.06%-64.47M
-25.51%-16.58M
-47.89%-17.54M
-54.56%-16.08M
-546.13%-14.26M
-23.00%-37.69M
-45.87%-13.21M
-247.68%-11.86M
-23.65%-10.4M
Net income continuous Operations
3.73%-13.73M
-71.06%-64.47M
-25.51%-16.58M
-47.89%-17.54M
-54.56%-16.08M
-546.13%-14.26M
-23.00%-37.69M
-45.87%-13.21M
-247.68%-11.86M
-23.65%-10.4M
Minority interest income
Net income attributable to the parent company
3.73%-13.73M
-71.06%-64.47M
-25.51%-16.58M
-47.89%-17.54M
-54.56%-16.08M
-546.13%-14.26M
-23.00%-37.69M
-45.87%-13.21M
-247.68%-11.86M
-23.65%-10.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
3.73%-13.73M
-71.06%-64.47M
-25.51%-16.58M
-47.89%-17.54M
-54.56%-16.08M
-546.13%-14.26M
-23.00%-37.69M
-45.87%-13.21M
-247.68%-11.86M
-23.65%-10.4M
Basic earnings per share
36.42%-1.03
40.17%-61.8
-316.67%-15
50.00%-1.6
48.28%-1.5
-170.00%-1.62
-284.01%-103.3
-50.47%-3.6
53.62%-3.2
-30.34%-2.9
Diluted earnings per share
36.42%-1.03
40.17%-61.8
-316.67%-15
50.00%-1.6
48.28%-1.5
-170.00%-1.62
-284.01%-103.3
-50.47%-3.6
53.62%-3.2
-30.34%-2.9
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 8.07%15.07M34.50%68.86M28.94%17.73M52.36%19.36M49.02%17.83M9.15%13.95M38.99%51.2M13.78%13.75M26.08%12.71M42.11%11.96M
Selling and administrative expenses 15.26%4.77M3.06%17.08M-12.88%3.89M22.46%4.51M18.34%4.53M-9.76%4.14M45.19%16.57M30.36%4.47M27.50%3.69M17.35%3.83M
-General and administrative expense 15.26%4.77M3.06%17.08M-12.88%3.89M22.46%4.51M18.34%4.53M-9.76%4.14M45.19%16.57M30.36%4.47M27.50%3.69M17.35%3.83M
Research and development costs 5.03%10.3M49.55%51.79M49.05%13.84M64.58%14.85M63.45%13.3M19.75%9.81M36.21%34.63M7.22%9.28M25.51%9.02M57.78%8.14M
Operating profit -8.07%-15.07M-34.50%-68.86M-28.94%-17.73M-52.36%-19.36M-49.02%-17.83M-9.15%-13.95M-38.99%-51.2M-13.78%-13.75M-26.08%-12.71M-42.11%-11.96M
Net non-operating interest income expense 26.46%1.39M641.65%5.2M254.60%1.23M453.28%1.43M1,460.87%1.44M54,700.00%1.1M701K348K2,977.78%259K92K
Non-operating interest income 26.46%1.39M641.65%5.2M254.60%1.23M453.28%1.43M1,460.87%1.44M54,700.00%1.1M--701K--348K--259K--92K
Other net income (expense) 97.02%-42K-106.27%-803K-147.87%-90K-34.30%385K-78.80%311K-113.33%-1.41M106.75%12.81M-93.78%188K-91.22%586K36,575.00%1.47M
Gain on sale of security -----107.99%-575K--0---------109.50%-575K339.92%7.2M200.00%150K-65.56%155K--845K
Special income (charges) 97.38%-20K-99.69%18K-67.06%28K-20.85%334K-32.80%420K-116.63%-764K-38.29%5.73M-97.21%85K-93.22%422K--625K
-Less:Restructuring and merger&acquisition -97.38%20K99.69%-18K67.06%-28K20.85%-334K32.80%-420K116.63%764K38.29%-5.73M97.21%-85K93.22%-422K---625K
Other non- operating income (expenses) 68.57%-22K-113.91%-246K-151.06%-118K466.67%51K-3,533.33%-109K5.41%-70K-43.75%-115K---47K--9K-175.00%-3K
Income before tax 3.73%-13.73M-71.06%-64.47M-25.51%-16.58M-47.89%-17.54M-54.56%-16.08M-546.13%-14.26M-23.00%-37.69M-45.87%-13.21M-247.68%-11.86M-23.65%-10.4M
Income tax
Net income 3.73%-13.73M-71.06%-64.47M-25.51%-16.58M-47.89%-17.54M-54.56%-16.08M-546.13%-14.26M-23.00%-37.69M-45.87%-13.21M-247.68%-11.86M-23.65%-10.4M
Net income continuous Operations 3.73%-13.73M-71.06%-64.47M-25.51%-16.58M-47.89%-17.54M-54.56%-16.08M-546.13%-14.26M-23.00%-37.69M-45.87%-13.21M-247.68%-11.86M-23.65%-10.4M
Minority interest income
Net income attributable to the parent company 3.73%-13.73M-71.06%-64.47M-25.51%-16.58M-47.89%-17.54M-54.56%-16.08M-546.13%-14.26M-23.00%-37.69M-45.87%-13.21M-247.68%-11.86M-23.65%-10.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 3.73%-13.73M-71.06%-64.47M-25.51%-16.58M-47.89%-17.54M-54.56%-16.08M-546.13%-14.26M-23.00%-37.69M-45.87%-13.21M-247.68%-11.86M-23.65%-10.4M
Basic earnings per share 36.42%-1.0340.17%-61.8-316.67%-1550.00%-1.648.28%-1.5-170.00%-1.62-284.01%-103.3-50.47%-3.653.62%-3.2-30.34%-2.9
Diluted earnings per share 36.42%-1.0340.17%-61.8-316.67%-1550.00%-1.648.28%-1.5-170.00%-1.62-284.01%-103.3-50.47%-3.653.62%-3.2-30.34%-2.9
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg